More Newsmaker Stories
For some cancer patients who have failed to respond to other therapies, treatment with their own genetically modified immune cells can mean the difference between life and death.
Says Chip Baldwin, whose cancer is now in remission, “I don’t think I would be here today if it wasn’t for CAR T.”
Diagnosed with an aggressive blood cancer that was growing into a major blood vessel in his chest, Mr. Baldwin was running out of treatment options when he was referred to the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC), a regional leader in CAR T-cell therapy.
In this video, he talks about his cancer journey and life after receiving this FDA-approved immunotherapy in April 2018.
His oncologist, Dr. Aaron Rapoport, director of UMGCCC’s Blood and Marrow Transplant Program, calls CAR T-cell therapy “one of the most exciting new developments in cancer therapy.” He talks about UMGCCC’s robust clinical and research program and the promise of using CAR T-cell therapy to treat more types of cancer.
- Package without CGs
- UMGCCC Expands CAR T-Cell Treatment Options | Press Release
Targeted radiation treatment is delivered in less treatments and spares radiation exposure to other organs including the heart and lungs.
The University of Maryland Medical Center Downtown Campus in Baltimore is the first place in the country to offer this innovative new treatment.
Learn more about GammaPod:
MRI-Guided Focused Ultrasound
With the potential to transform the treatment of many medical disorders by using ultrasonic energy to target tissue deep in the body without incisions or radiation, focused ultrasound is an early-stage, non-invasive therapeutic technology offering new hope to patients.
University of Maryland Medical Center physician scientists are pioneering the use of MRI-guided focused ultrasound to become a new standard of care for treating many common and devastating brain diseases including Parkinson's, essential tremor, neuropathic pain and glioblastoma, an often deadly type of brain cancer.
- Focused Ultrasound to Treat Parkinson's Disease | Press Release
- Focused Ultrasound to Open Blood-Brain Barrier | Press Release
- Man Finds Golf Swing After Essential Tremor Treatment | Patient Story
- ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease
- Second clinical trial to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson's disease
- Clinical trial for glioblastoma which uses MRI-guided focused ultrasound
Stem Cell Research
Can adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS)?
That is what Sunjay Kaushal, MD, PhD, professor of surgery at the University of Maryland School of Medicine and director, pediatric cardiac surgery, University of Maryland Children’s Hospital, is leading research to find out.
In HLHS, the left ventricle does not develop completely during a critical growth period just prior to birth. The hope is that the stem cells improve the heart’s pumping ability.